Ontology highlight
ABSTRACT:
SUBMITTER: Jauset T
PROVIDER: S-EPMC5922351 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
Jauset Toni T Massó-Vallés Daniel D Martínez-Martín Sandra S Beaulieu Marie-Eve ME Foradada Laia L Fiorentino Francesco Paolo FP Yokota Jun J Haendler Bernard B Siegel Stephan S Whitfield Jonathan R JR Soucek Laura L
Oncotarget 20180410 27
Effectively treating KRAS-driven tumors remains an unsolved challenge. The inhibition of downstream signaling effectors is a way of overcoming the issue of direct targeting of mutant KRAS, which has shown limited efficacy so far. Bromodomain and Extra-Terminal (BET) protein inhibition has displayed anti-tumor activity in a wide range of cancers, including KRAS-driven malignancies. Here, we preclinically evaluate the effect of BET inhibition making use of a new BET inhibitor, BAY 1238097, against ...[more]